Sexual health in midlife is one of the most consistently underdiscussed topics in medicine. Surveys from the North American Menopause Society and others repeatedly find that most women want their clinicians to ask about it, most clinicians do not, and both parties end up quietly assuming the other is not interested. The result is a wide gap between what women experience and what they know can be treated.
The biology of midlife sexuality is not primarily about libido as a moral quantity. It is about tissue, blood flow, hormones, sleep, mental health, medications, relationships, and, often, the accumulated weight of years of not talking about it.
What actually changes
Several things happen around and after menopause that reliably affect sexual function.
- Vaginal and vulvar tissue changes. As estrogen falls, the vaginal walls become thinner, less elastic, and less lubricated. The vulva can lose fullness, and the urethra becomes more prone to irritation and infection. This cluster of changes is called the genitourinary syndrome of menopause, or GSM.
- Reduced natural lubrication. Arousal-related lubrication decreases, and time-to-arousal often lengthens.
- Shifts in desire. Spontaneous desire tends to decrease, while responsive desire, which emerges in the context of physical closeness or stimulation, often remains intact. Understanding this distinction changes the framing of many midlife sexual concerns.
- Orgasm changes. Sensation and orgasm intensity can shift, though most women continue to be orgasmic if they were previously.
Many of these changes are gradual and go unattributed to menopause until they become uncomfortable. Painful sex, in particular, is a common reason women stop having it, which then reinforces the tissue changes.
What treatment actually looks like
Some of the most effective interventions in midlife sexual health are the least often offered.
- Local vaginal estrogen. Endorsed by the North American Menopause Society and the American College of Obstetricians and Gynecologists for GSM, low-dose vaginal estrogen (creams, tablets, or rings) is highly effective at restoring tissue health, reducing pain with sex, and lowering urinary tract infection recurrence. Systemic absorption is minimal, and it is considered appropriate for most women, including many with a personal history of breast cancer after discussion with their oncology team.
- Non-hormonal options. Vaginal moisturizers used regularly, lubricants at the time of sex, and prescription non-hormonal medications such as ospemifene and prasterone (DHEA) are all reasonable choices depending on preference and history.
- Systemic hormone therapy. For women with bothersome vasomotor symptoms and no contraindications, systemic estrogen (with progestogen if the uterus is intact) is appropriate and can also help sexual function.
- Pelvic floor physical therapy. Underused, and often the missing piece when pain persists despite tissue treatment.
- Medication review. SSRIs, some blood pressure medications, and others can meaningfully affect desire and orgasm. Alternatives may exist.
Painful sex after menopause is common. It is not, medically speaking, something you are supposed to live with.
Desire, relationships, and the wider picture
Desire is not purely biological. Sleep quality, mood, body image, relationship dynamics, stress, and how a partner has responded to changing bodies all shape what happens in bed. Cognitive-behavioral therapy for sexual concerns, mindfulness-based approaches, and sex therapy with a certified therapist have a stronger evidence base than most people realize.
Communication tends to be the underrated intervention. Couples who have not updated their assumptions about each other's bodies, preferences, and desire patterns often bring years of outdated data into the current relationship.
Bringing it up in the exam room
You may need to be the one to open the topic. A few phrasings that work:
- "Sex has become painful. I would like to talk about what to do."
- "My desire has changed. I want to understand whether something treatable is contributing."
- "I have been having urinary symptoms and dryness. Is vaginal estrogen an option for me?"
If the response is dismissive, asking directly for a referral to a menopause specialist or a sexual medicine clinician is reasonable.
The bottom line
Sexual function in midlife and beyond is treatable, and the tools, from local estrogen to pelvic floor therapy to updated conversations about desire, are underused rather than unavailable. Painful sex, dryness, changes in desire, and orgasm difficulties are medical concerns worth naming plainly. The most common obstacle is not biology. It is silence.